Skip to content

Perspectives blog

Explore the latest blogs and compelling articles about echocardiography, new research, and advances in technology.

Putting AI-Powered EchoGo® Devices into Practice at City of Hope Comprehensive Cancer Center

Putting AI-Powered EchoGo® Devices into Practice at City of Hope Comprehensive Cancer Center

Dr. Faizi Jamal shares how EchoGo® Heart Failure and EchoGo® Amyloidosis are integrated into clinical workflows to support early, more informed diagnosis.
Implementing EchoGo® Heart Failure: An interview with Dr. Andres Schuster

Implementing EchoGo® Heart Failure: An interview with Dr. Andres Schuster

Learn how Dr Schuster at University Cleveland Hospitals discusses his motives for using AI to detect HFpEF and the process of implementing AI into clinical practice.
How does Artificial Intelligence improve diagnosis for Cardiac Amyloidosis?

How does Artificial Intelligence improve diagnosis for Cardiac Amyloidosis?

Learn how AI-driven echocardiography is revolutionizing detection of cardiac amyloidosis. Discover the impact of faster, more accurate detection for improved patient care.
Diagnosing Cardiac Amyloidosis: Challenges and Current Gaps in Detection

Diagnosing Cardiac Amyloidosis: Challenges and Current Gaps in Detection

Explore challenges in cardiac amyloidosis diagnosis, from delays to misdiagnoses, and how AI could improve early detection and patient outcomes.
Reimbursement for AI in Echo: Navigating the Landscape

Reimbursement for AI in Echo: Navigating the Landscape

Ross Upton CEO and Founder of Ultromics explores the challenges and strategies for securing reimbursement for AI-driven echocardiography, essential for market success and patient care.
AI’s growing impact in heart failure detection

AI’s growing impact in heart failure detection

Ultromics co-founder and CMO Professor Paul Leeson shares his opinion on the growing impact AI is having on heart failure detection.
Cardiac Amyloidosis: Causes, Symptoms and Treatments

Cardiac Amyloidosis: Causes, Symptoms and Treatments

Uncover the causes, symptoms, and treatments for cardiac amyloidosis, offering hope and insights into managing this complex condition
What is Cardiac Amyloidosis?

What is Cardiac Amyloidosis?

"Learn how Ultromics secured four FDA clearances and two Breakthrough Designations in just four years. Explore our journey of innovation!"
Riding the wave of innovation How to secure four FDA clearances and two FDA Breakthrough Designations in four years

Riding the wave of innovation How to secure four FDA clearances and two FDA Breakthrough Designations in four years

"Learn how Ultromics secured four FDA clearances and two Breakthrough Designations in just four years. Explore our journey of innovation!"
10 Years in the Making: The Clinical Application of AI-Based Echocardiography Diagnostics

10 Years in the Making: The Clinical Application of AI-Based Echocardiography Diagnostics

SGLT2 inhibitors are emerging as a new and effective therapeutic option for patients with heart failure with preserved ejection fraction (HFpEF)
Top Advances in Echocardiography Transforming Cardiac Imaging on World Heart Day

Top Advances in Echocardiography Transforming Cardiac Imaging on World Heart Day

In honor of World Heart Day on September 29, we're diving into the world of cardiovascular diagnostics with top advances in echocardiography this last year.
Ultromics at the American Society of Echocardiography’s 2023 Scientific Sessions

Ultromics at the American Society of Echocardiography’s 2023 Scientific Sessions

Ultromics will share its groundbreaking AI research and innovation at the American Society of Echocardiography’s 2023 Scientific Sessions

Curious about upcoming research and innovation?

Sign up to hear about the latest news. 

Sign up to newsletter